Paula J. Andryuk

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

Julio Rosenstock, Ronald Brazg, Paula J. Andryuk et al. · Clinical Therapeutics · 2006 · 513 citations

Diabetes Management, Medicine, Pioglitazone Therapy +8

Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes

Tina Vilsbøll, Julio Rosenstock, H Yki-Järvinen et al. · Diabetes Obesity and Metabolism · 2009 · 303 citations · Full text

Three distinct human thymopoietins are derived from alternatively spliced mRNAs.

Crafford A. Harris, Paula J. Andryuk, Scott W. Cline et al. · Proceedings of the National Academy of Sciences · 1994 · 111 citations · Full text

Laboratory Immunology, Genetics, T-regulatory Cell +19

Structure and Mapping of the Human Thymopoietin (TMPO) Gene and Relationship of Human TMPO β to Rat Lamin-Associated Polypeptide 2

Crafford A. Harris, Paula J. Andryuk, Scott W. Cline et al. · Genomics · 1995 · 88 citations

Human Thymopoietin, Lamin-associated Polypeptide 2, Genetics +4

Glucagon receptor antagonism induces increased cholesterol absorption

Hong-Ping Guan, Xiaodong Yang, Ku Lu et al. · Journal of Lipid Research · 2015 · 76 citations · Full text